NOVA PHARMA SOLUTIONS BERHAD

KLSE (MYR): NPS (03006)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

0.225

Today's Change

0.00 (0.00%)

Day's Change

0.00 - 0.00

Trading Volume

0

Overview

Market Cap

34 Million

NOSH

149 Million

Avg Volume (4 weeks)

0

4 Weeks Range

0.00 - 0.00

4 Weeks Price Volatility (%)

0.00%

52 Weeks Range

0.00 - 0.00

52 Weeks Price Volatility (%)

0.00%

Previous Close

0.225

Open

0.00

Bid

0.00 x 0

Ask

0.00 x 0

Day's Range

0.00 - 0.00

Trading Volume

0

Financial Highlight

Latest Quarter | Ann. Date

30-Jun-2024 [#1] | 26-Aug-2024

Next QR | Est. Ann. Date

30-Sep-2024 | 26-Nov-2024

T4Q P/E | EY

8.92 | 11.21%

T4Q DY | Payout %

0.00% | 0.00%

T4Q NAPS | P/NAPS

0.11 | 2.05

T4Q NP Margin | ROE

37.16% | 22.93%

Market Buzz
Company Profile

Sector: HEALTH CARE

Sector: HEALTH CARE

Subsector: PHARMACEUTICALS

Subsector: PHARMACEUTICALS

Description:

Nova Pharma Solutions Berhad is a Malaysia-based company, which is principally engaged in the business of provision of technical documentation, validation and project execution in the pharmaceutical and biological industries. The Company operates through four segments. Design fee segment comprise of conceptual designs, which include user requirement specification, capacity analysis and process scheduling with detailed costing, list of deliverables, details specification of various equipment and processes, as well as authorities' compliance requirements. Post design fee segment comprise of tendering and procurement support, as well as construction of plant. Other support fee segment comprises of services to assist customer in the manufacturing practice document review and gap analysis and assessment. EPCC comprise of works and services pertaining to engineering and /or procurement and /or construction and /or commissioning for advanced technology facilities.

Discussions
Be the first to like this. Showing 1 of 1 comments

mf

Post removed.Why?

2020-08-07 19:31

Post a Comment